Brand
name : COLOSPA
(Colofac, Mebeverine)
Mebeverine Hydrochloride
Presentation
COLOSPA (Colofac, Mebeverine) tablet: Each tablet contains Mebeverine Hydrochloride BP 135
mg.
Description
COLOSPA (Colofac, Mebeverine) is a musculotropic antispasmodic agent used to relieve cramps
or spasms of the stomach and intestines (gut). It is particularly
useful in treating irritable bowel syndrome (IBS) and similar conditions.
It works by relaxing the muscles and helping to restore the normal
movement of the gut.
Indications and Uses
COLOSPA (Colofac, Mebeverine) is indicated
For the symptomatic treatment of irritable bowel syndrome (IBS)
Other conditions include:
Chronic irritable colon
Spastic constipation
Mucous colitis
Colicky abdominal pain
Persistent non-specific diarrhoea
Contraindications
Not known
Dosage And Administration
Adults, elderly and children over 10 years: One tablet three times
a day.
COLOSPA (Colofac, Mebeverine) is most effective when taken 20 minutes before meals. After
a several weeks when the desired effect has been obtained, the dosage
may be gradually reduced.
*Missed dose: If a dose of this medicine is missed that should be
taken as soon as possible. However, if it is almost time for the next
dose, then skip the missed dose and the regular dosing schedule should
be maintained. Dose should not be doubled at the same time to compensate
the missed dose.
Precautions
Caution should be exercised in porphyria or allergic reaction to this
or any other medicine.
Side Effects COLOSPA (Colofac, Mebeverine)
Generally Mebeverine is well tolerated. However, few side-effects like
skin rash, urticaria and angioedema may appear.
Use in pregnancy & lactation
No teratogenicity has been shown in animal experiments. However, the
usual precautions concerning the administration of any drug during
pregnancy should be exercised.
Mebeverine does not excrete in the breast milk after administering
the therapeutic dose.
Use in children
Mebeverine is not recommended in children under 10 years.
Overdosage
On theoretical grounds it may be predicted that CNS excitability will
occur in case of overdosage. No specific antidote is known: gastric
lavage and symptomatic treatment is recommended.
Commercial Pack
